Rydex Inverse 2x S&P Select Sector Hlth (RHO) News
Track canonical SquawkNews coverage tagged to RHO, Rydex Inverse 2x S&P Select Sector Hlth. This hub brings together deduplicated headlines about nasdaqgs, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Roche to pay Simcere $75 million upfront for blood cancer drug rights
Roche will pay $75 million upfront to Simcere Pharmaceutical Group for rights to an experimental blood cancer drug, Simcere said Tuesday.
EQUITY | Sep 01, 2026, 11:02 AM UTC
M
Simcere Pharmaceutical signs exclusive global licensing deal for SIM0660
Simcere Pharmaceutical Group entered an exclusive global licensing agreement with Roche for SIM0660, according to TradingView News.
EQUITY | Sep 01, 2026, 10:26 AM UTC